Olanzapine 2.5mg/5ml oral suspension
BNF presentation 040201060AABABA within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040201060AABABA
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
303
NHS spend (£)
£12,986.19
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 55 |
| December 2024 | 2 |
| November 2024 | 60 |
| October 2024 | 82 |
| August 2024 | 4 |
| July 2024 | 40 |
| May 2024 | 11 |
| July 2021 | 14 |
| June 2021 | 2 |
| December 2020 | 12 |
| November 2020 | 21 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 82 | No data available |
| Unknown pharmacy | 8 | No data available |
| Unknown pharmacy | 8 | No data available |
|
John Tasker House Surgery
ODS F81118
|
7 | 07H - HERTFORDSHIRE AND WEST ESSEX ICB |
| Unknown pharmacy | 7 | No data available |
| Unknown pharmacy | 6 | No data available |
|
Rothschild House Group
ODS E82001
|
6 | 06N - HERTFORDSHIRE AND WEST ESSEX ICB |
| Unknown pharmacy | 6 | No data available |
| Unknown pharmacy | 5 | No data available |
| Unknown pharmacy | 5 | No data available |